Quest Diagnostics Incorporated Stock EBITDA

DGX Stock

USD 163.32 1.05 0.65%

Quest Diagnostics Incorporated fundamentals help investors to digest information that contributes to Quest Diagnostics' financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest Diagnostics stock.

		Last Reported	Projected for Next Year
	EBITDA	1.3 B	1.3 B

EBITDA is likely to rise to about 1.3 B in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Quest Diagnostics Incorporated Company EBITDA Analysis

Quest Diagnostics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Quest Diagnostics EBITDA

1.26 B

Most of Quest Diagnostics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest Diagnostics Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Quest EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Quest Diagnostics is extremely important. It helps to project a fair market value of Quest Stock properly, considering its historical fundamentals such as EBITDA. Since Quest Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Quest Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Quest Diagnostics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.91	0.86	0.67	0.94	0.99	0.87	0.4	0.82	0.92	0.96	0.57	0.96	-0.8	-0.37	0.35	0.78	0.37	0.27	-0.31	0.39	0.56	0.48	0.01
Total Stockholder Equity	0.99		0.86	0.88	0.71	0.95	0.96	0.87	0.31	0.78	0.91	0.94	0.59	0.95	-0.81	-0.37	0.42	0.78	0.4	0.33	-0.38	0.4	0.57	0.51	0.01
Net Debt	0.91	0.86		0.75	0.41	0.75	0.94	0.62	0.49	0.9	0.89	0.95	0.46	0.95	-0.75	-0.26	-0.02	0.66	0.24	0.15	-0.14	0.1	0.33	0.13	0.01
Retained Earnings	0.86	0.88	0.75		0.64	0.82	0.83	0.73	0.3	0.69	0.85	0.85	0.75	0.88	-0.91	-0.47	0.37	0.8	0.62	0.41	-0.27	0.38	0.7	0.45	-0.38
Accounts Payable	0.67	0.71	0.41	0.64		0.81	0.63	0.84	0.1	0.28	0.5	0.54	0.66	0.55	-0.44	-0.62	0.73	0.75	0.34	0.13	-0.5	0.58	0.77	0.85	-0.21
Net Receivables	0.94	0.95	0.75	0.82	0.81		0.91	0.93	0.29	0.68	0.85	0.85	0.61	0.87	-0.7	-0.43	0.49	0.74	0.32	0.22	-0.44	0.51	0.63	0.69	0.0
Total Liab	0.99	0.96	0.94	0.83	0.63	0.91		0.85	0.48	0.85	0.91	0.97	0.55	0.97	-0.77	-0.35	0.27	0.75	0.33	0.2	-0.22	0.38	0.53	0.44	0.01
Total Current Assets	0.87	0.87	0.62	0.73	0.84	0.93	0.85		0.4	0.54	0.7	0.75	0.58	0.73	-0.59	-0.46	0.64	0.75	0.39	0.22	-0.26	0.75	0.75	0.81	-0.05
Short Term Debt	0.4	0.31	0.49	0.3	0.1	0.29	0.48	0.4		0.3	0.49	0.33	0.18	0.37	-0.33	-0.41	0.0	0.28	0.27	0.06	0.58	0.43	0.35	0.08	-0.03
Common Stock	0.82	0.78	0.9	0.69	0.28	0.68	0.85	0.54	0.3		0.79	0.91	0.28	0.9	-0.72	0.07	-0.16	0.44	0.23	0.15	-0.14	0.04	0.16	0.09	0.02
Intangible Assets	0.92	0.91	0.89	0.85	0.5	0.85	0.91	0.7	0.49	0.79		0.89	0.52	0.93	-0.83	-0.38	0.15	0.67	0.44	0.34	-0.2	0.24	0.45	0.3	-0.03
Long Term Debt	0.96	0.94	0.95	0.85	0.54	0.85	0.97	0.75	0.33	0.91	0.89		0.51	0.98	-0.82	-0.24	0.17	0.74	0.35	0.29	-0.31	0.25	0.43	0.34	-0.03
Property Plant Equipment	0.57	0.59	0.46	0.75	0.66	0.61	0.55	0.58	0.18	0.28	0.52	0.51		0.58	-0.45	-0.6	0.36	0.84	0.3	-0.07	-0.25	0.31	0.87	0.52	-0.68
Good Will	0.96	0.95	0.95	0.88	0.55	0.87	0.97	0.73	0.37	0.9	0.93	0.98	0.58		-0.83	-0.3	0.14	0.73	0.34	0.22	-0.28	0.21	0.47	0.31	-0.09
Treasury Stock	-0.8	-0.81	-0.75	-0.91	-0.44	-0.7	-0.77	-0.59	-0.33	-0.72	-0.83	-0.82	-0.45	-0.83		0.35	-0.28	-0.61	-0.68	-0.61	0.2	-0.28	-0.42	-0.23	0.12
Current Deferred Revenue	-0.37	-0.37	-0.26	-0.47	-0.62	-0.43	-0.35	-0.46	-0.41	0.07	-0.38	-0.24	-0.6	-0.3	0.35		-0.51	-0.64	-0.29	-0.19	0.21	-0.45	-0.64	-0.48	0.27
Net Tangible Assets	0.35	0.42	-0.02	0.37	0.73	0.49	0.27	0.64	0.0	-0.16	0.15	0.17	0.36	0.14	-0.28	-0.51		0.5	0.43	0.44	-0.35	0.73	0.63	0.75	0.01
Long Term Debt Total	0.78	0.78	0.66	0.8	0.75	0.74	0.75	0.75	0.28	0.44	0.67	0.74	0.84	0.73	-0.61	-0.64	0.5		0.47	0.24	-0.33	0.41	0.81	0.57	-0.4
Capital Surpluse	0.37	0.4	0.24	0.62	0.34	0.32	0.33	0.39	0.27	0.23	0.44	0.35	0.3	0.34	-0.68	-0.29	0.43	0.47		0.74	0.1	0.39	0.52	0.29	-0.39
Long Term Investments	0.27	0.33	0.15	0.41	0.13	0.22	0.2	0.22	0.06	0.15	0.34	0.29	-0.07	0.22	-0.61	-0.19	0.44	0.24	0.74		-0.18	0.29	0.09	0.11	0.12
Short Long Term Debt	-0.31	-0.38	-0.14	-0.27	-0.5	-0.44	-0.22	-0.26	0.58	-0.14	-0.2	-0.31	-0.25	-0.28	0.2	0.21	-0.35	-0.33	0.1	-0.18		0.04	-0.06	-0.39	-0.14
Cash And Equivalents	0.39	0.4	0.1	0.38	0.58	0.51	0.38	0.75	0.43	0.04	0.24	0.25	0.31	0.21	-0.28	-0.45	0.73	0.41	0.39	0.29	0.04		0.66	0.81	-0.08
Net Invested Capital	0.56	0.57	0.33	0.7	0.77	0.63	0.53	0.75	0.35	0.16	0.45	0.43	0.87	0.47	-0.42	-0.64	0.63	0.81	0.52	0.09	-0.06	0.66		0.74	-0.61
Net Working Capital	0.48	0.51	0.13	0.45	0.85	0.69	0.44	0.81	0.08	0.09	0.3	0.34	0.52	0.31	-0.23	-0.48	0.75	0.57	0.29	0.11	-0.39	0.81	0.74		-0.2
Capital Stock	0.01	0.01	0.01	-0.38	-0.21	0.0	0.01	-0.05	-0.03	0.02	-0.03	-0.03	-0.68	-0.09	0.12	0.27	0.01	-0.4	-0.39	0.12	-0.14	-0.08	-0.61	-0.2

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Quest Diagnostics

Ebitda Over Time

Quest Ebitda

Ebitda

1.34 Billion

At this time, Quest Diagnostics' EBITDA is fairly stable compared to the past year.

According to the company disclosure, Quest Diagnostics Incorporated reported earnings before interest,tax, depreciation and amortization of 1.26 B. This is 43.83% higher than that of the Health Care Providers & Services sector and 263.79% higher than that of the Health Care industry. The ebitda for all United States stocks is 67.63% higher than that of the company.

Quest EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest Diagnostics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest Diagnostics could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics of similar companies.

Quest Diagnostics is currently under evaluation in ebitda category among its peers.

Quest Diagnostics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Quest Diagnostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quest Diagnostics' managers, analysts, and investors.

Environmental

Governance

Social

Quest Diagnostics Institutional Holders

Institutional Holdings refers to the ownership stake in Quest Diagnostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Quest Diagnostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Quest Diagnostics' value.

		Shares
Amvescap Plc.	2024-06-30	1.8 M
Goldman Sachs Group Inc	2024-06-30	1.7 M
Jpmorgan Chase & Co	2024-06-30	1.5 M
Wells Fargo & Co	2024-06-30	1.5 M
Fiduciary Management, Inc. Of Milwaukee	2024-09-30	1.4 M
Norges Bank	2024-06-30	1.3 M
Fmr Inc	2024-09-30	1.1 M
Northern Trust Corp	2024-09-30	1 M
Legal & General Group Plc	2024-06-30	959.6 K
Vanguard Group Inc	2024-09-30	14 M
Blackrock Inc	2024-06-30	10.1 M

Quest Fundamentals

	Return On Equity	0.13
	Return On Asset	0.0566
	Profit Margin	0.09 %
	Operating Margin	0.14 %
	Current Valuation	24.43 B
	Shares Outstanding	111.61 M
	Shares Owned By Insiders	0.43 %
	Shares Owned By Institutions	91.60 %
	Number Of Shares Shorted	2.59 M
	Price To Earning	14.57 X
	Price To Book	2.66 X
	Price To Sales	1.91 X
	Revenue	9.25 B
	Gross Profit	3.47 B
	EBITDA	1.26 B
	Net Income	908 M
	Cash And Equivalents	315 M
	Cash Per Share	6.15 X
	Total Debt	5.5 B
	Debt To Equity	0.73 %
	Current Ratio	1.46 X
	Book Value Per Share	60.80 X
	Cash Flow From Operations	1.27 B
	Short Ratio	2.69 X
	Earnings Per Share	7.45 X
	Price To Earnings To Growth	1.89 X
	Target Price	167.29
	Number Of Employees	50 K
	Beta	0.89
	Market Capitalization	18.23 B
	Total Asset	14.02 B
	Retained Earnings	8.82 B
	Working Capital	557 M
	Current Asset	1.5 B
	Current Liabilities	1.17 B
	Annual Yield	0.02 %
	Five Year Return	1.89 %
	Net Asset	14.02 B
	Last Dividend Paid	2.96

About Quest Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Quest Diagnostics Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest Diagnostics Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC